1. Home
  2. TEVA

as of 07-27-2026 9:30am EST

$31.15
+$0.34
+1.10%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Founded: 1901 Country:
Israel
Israel
Employees: 32842 City: TEL AVIV
Market Cap: 37.1B IPO Year: N/A
Target Price: $38.63 AVG Volume (30 days): 4.2M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $14.99 - $37.34 Next Earning Date: 04-29-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -1.62% Revenue Growth (next year): 2.97%
P/E Ratio: 28.19 Index: N/A
Free Cash Flow: N/A FCF Growth: +53.20%

Share on Social Networks: